However, in patients with breast cancer, the pooled result of three datasets showed that decreased FOXP1 expression was significantly correlated with an unfavorable RFS (HR = 1.93, 95%CI: 1.33–2.80, p = 0.001) (Fig. 6). Here, FOXP1 is linked to breast carcinoma.